PDMR Shareholding
Updated : 13:47
IndigoVision Group plc
("IndigoVision" or the "Company")
PDMR Shareholding
IndigoVision Group plc announces that it has been notified that on 23 May 2019 Dean Brazenall, Vice President Sales - EMEA, purchased 2,000 ordinary shares in the capital of the Company ("Ordinary Shares") at a price of £1.86 per Ordinary Share.
Following the transaction, Dean Brazenall's total shareholding in the Company is 13,648 Ordinary Shares, representing 0.18 per cent. of IndigoVision's issued voting share capital.
For further information:
IndigoVision Group plc | |
Chris Lea | +44 (0)131 475 7200 |
N+1 Singer | |
Sandy Fraser | +44 (0)20 7496 3176
|
1
| Details of the person discharging managerial responsibilities / person closely associated
| ||
a) | Name | Dean Brazenall | |
2 | Reason for the notification | ||
a) | Position/status | Vice President Sales - EMEA | |
b) | Initial notification /Amendment | Initial | |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | IndigoVision Group plc | |
b) | LEI | 213800UTDZWYBP2YR191 | |
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a)
| Description of the financial instrument, type of instrument
Identification code
| Ordinary shares of 1 pence each
GB0032654534
| |
b) | Nature of the transaction | Purchase | |
c)
| Price(s) and volume(s)
| Price | Volume |
£1.86 | 2,000 | ||
d)
| Aggregated information
- Aggregated volume
- Price
|
n/a
| |
e) | Date of the transaction | 23 May 2019 | |
f) | Place of the transaction | London Stock Exchange |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.